Critical role of L-arginine in endothelial cell survival during oxidative stress

Circulation

Volumn 107, Issue 20, 2003, Pages 2607-2614

  Suschek, Christoph V ^a   Schnorr, Oliver ^a   Hemmrich, Karsten ^a   Lars Oliver Klotz, Olivier Aust ^a   Sies, Helmut ^a   Kolb Bachofen, Victoria ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Amino acids; Arteriosclerosis; Endothelium; Inflammation; Nitric oxide

Indexed keywords

AMINO ACID TRANSPORTER; ARGINASE; ARGININE; CYTOKINE; HYDROGEN PEROXIDE; LIPID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL SURVIVAL; CELL VIABILITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GENE SEQUENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFLAMMATION; LIPID PEROXIDATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

EID: 0038689296     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.0000066909.13953.f1     Document Type: Article

References (25)

1. Miigge A. The role of reactive oxygen species in atherosclerosis. Z Kardiol. 1998;87:851-864.
2. Kröncke KD, Fehsel K, Suschek C, et al. Inducible nitric oxide synthasederived nitric oxide in gene regulation, cell death and cell survival. Int Immunopharmacol. 2001;1:1407-1420.
3. Ihrig M, Dangler CA, Fox JG. Mice lacking inducible nitric oxide synthase develop spontaneous hypercholesterolaemia and aortic atheromas. Atherosclerosis. 2001;156:103-107.
4. von der Leyen HE, Dzau VJ. Therapeutic potential of nitric oxide synthase gene manipulation. Circulation. 2001;103:2760-2765.
5. Peng HB, Spiecker M, Liao JK. Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J Immunol. 1998;161:1970-1976.
6. Kröncke KD, Fehsel K, Kolb-Bachofen V. Nitric oxide: cytotoxicity versus cytoprotection: how, why, when, and where? Nitric Oxide. 1997;1:107-120.
7. Closs EI, Scheld JS, Sharafi M, et al. Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol Pharmacol. 2000;57:68-74.
8. Preik-Steinhoff H, Zink S, Rosen P, et al. Transport of L-arginine in arginine-deprived endothelial cells. Biochem Biophys Res Commun. 1995;213:447-453.
9. Nijveldt RJ, Prins HA, van Kemenade FJ, et al. Low arginine plasma levels do not aggravate renal blood flow after experimental renal ischaemia/reperfusion. Eur J Vasc Endovasc Surg. 2001;22:232-239.
10. Suschek C, Fehsel K, Kröncke KD, et al. Primary cultures of rat islet capillary endothelial cells: constitutive and cytokine-inducible macrophagelike nitric oxide synthases are expressed and activities regulated by glucose concentration. Am J Pathol. 1994;145:685-695.
11. Riddell RJ, Clothier RH, Balls M. An evaluation of three in vitro cytotoxicity assays. Food Chem Toxicol. 1986;24:469-471.
12. Suschek CV, Briviba K, Bruch-Gerharz D, et al. Even after UVA-exposure will nitric oxide protect cells from reactive oxygen intermediate-mediated apoptosis and necrosis. Cell Death Differ. 2001;8:515-527.
13. Horakova L, Briviba K, Sies H. Antioxidant activity of the pyridoindole stobadine in liposomal and microsomal lipid peroxidation. Chem Biol Interact. 1992;83:85-93.
14. Dimmeler S, Zeiher AM. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res. 2000;87:434-439.
15. Böger RH, Bode-Böger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol. 2001;41:79-99.
16. Wink DA, Miranda KM, Espey MG, et al. Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Signal. 2001;3:203-213.
17. Barbul A, Lazarou SA, Efron DT, et al. Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery. 1990;108:331-336.
18. Gobert AP, Daulouede S, Lepoivre M, et al. L-Arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis. Infect Immunol. 2000;68:4653-4657.
19. Cooke JP. Is atherosclerosis an arginine deficiency disease? J Invest Med. 1998;46:377-380.
20. Mori M, Gotoh T. Regulation of nitric oxide production by arginine metabolic enzymes. Biochem Biophys Res Commun. 2000;275:715-719.
21. Buga GM, Singh R, Pervin S, et al. Arginase activity in endothelial cells: inhibition by NG-hydroxy-L-arginine during high-output NO production. Am J Physiol. 1996;271:H1988-H1998.
22. Rajagopalan S, Meng XP, Ramasamy S, et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: implications for atherosclerotic plaque stability. J Clin Invest. 1996;98:2572-5279.
23. Kolpakov V, Gordon D, Kulik TJ. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res. 1995;76:305-309.
24. Cannon RO III. Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin Chem. 1998;44:1809-1819.
25. Wang BY, Ho HK, Lin PS, et al. Regression of atherosclerosis: role of nitric oxide and apoptosis. Circulation. 1999;99:1236-1241.